Aidoc received 510(k) clearance from the FDA for its triage and notification of pneumothorax during X-ray examinations. Aidoc’s seven other FDA-cleared solutions are already being implemented in US healthcare systems, flagging and communicating suspected pathologies during CT exams.
Aidoc’s newly FDA cleared solution works on all X-ray machines, including portable devices, and is designed to analyze X-ray images. It automatically flags positive cases of pneumothorax, allowing doctors to read x-rays in a timely manner.
The ability to identify pneumothorax early is imperative because it can quickly worsen and lead to respiratory or heart failure. However, this is easier said than done, due to the large imaging volumes that radiologists must continuously review. Aidoc’s highly accurate AI pneumothorax algorithm addresses this challenge by analyzing X-rays, flagging and notifying physicians of suspected findings.
Elad Walach, CEO of Aidoc, said, “We are delighted with this important milestone. This FDA clearance further validates the breadth of our AI platform, going beyond specific AI algorithms to act as a healthcare AI hub for cross-specialty enterprise needs. This includes emergencies, intensive care, ambulatory care centers, hospitalizations, and the coordination of care and communication between providers. By bringing together radiologists and procedurals on the same AI platform, we enable better collaboration between departments and systems to provide patients with the right treatment at the right time. »
Aidoc’s AI platform processes large volumes of scans and images without disrupting the physician’s workflow. Existing Aidoc partners adding the pneumothorax solution to their portfolio will require no additional integration, infrastructure or maintenance effort.